[email protected]
Employee Login
ICMR - National AIDS Research Institute
Logo Thing main logo
Logo Thing main logo

Profile

Dr. Anupam Mukherjee
Name : Dr. Anupam Mukherjee
Designation : Scientist E, RAMANUJAN Fellow & Head
Division : Virology
Email ID : [email protected]; [email protected]
Area Of Interest : Dr. Mukherjee's laboratory is dedicated to a paramount research goal of discovering innovative interventions to combat HIV and its associated viral infections. Their research endeavors revolve around the meticulous examination of virus-host interactions, both in controlled in vitro settings and dynamic in vivo contexts. Driven by a profound curiosity, they delve deep into elucidating the multifaceted roles played by viral and cellular organelles, possessing the potential to regulate, modulate, or inflict pathogenicity. The primary concentration of Dr. Mukherjee’s research group is directed towards unraveling the complex web of functional and structural prerequisites governing viral replication while scrutinizing the intricate mechanisms triggered by viral proteins that culminate in pathogenicity. To translate this visionary pursuit into tangible outcomes, Dr. Mukherjee and their dedicated team wholeheartedly engage in foundational research encompassing Discovery, Development, and Delivery studies. This research paradigm places a significant emphasis on conducting rigorous pre-clinical experiments, capitalizing on an array of cutting-edge tools including small RNAs, broad-spectrum antivirals, phyto-pharmaceuticals, and traditional medicinal compounds, all harnessed as potential therapeutics. Upon meticulously identifying and characterizing these bioactive molecules, Dr. Mukherjee's research team meticulously assesses their susceptibility to specific viruses, explores targeted delivery systems utilizing state-of-the-art nano-particles, and meticulously evaluates the post-delivery outcomes. Consequently, his research interests not only aspire to shed light on novel and alternative medical approaches but also harbor the potential to paving the way for the development of bedside treatments capable of effectively eradicating pernicious viral pathogens.
Completed and Ongoing Projects

Ongoing Projects:

  1. miRNA Loaded Nanoparticles: Investigation and Validation of Targeted miRNA Delivery as A Prospective Antiviral Approach Against HSV-2 Infection. SERB-DST: 2022-2025; Role: Principal Investigator
  2. Investigation of the Efficiency of microRNA (miRNA) Loaded Nanoparticles in the Inflammasome-Mediated Extenuation of HSV-2 Pathogenesis. DHR-HRD: 2021-2024; Role: Principal Investigator/Mentor
  3. Exploration of Ayurveda-based Rasayana Botanicals for Biological Synthesis of Nanoparticles and its Application as HIV-1 Inhibitors Through in vitro Studies. DHR-HRD: 2021-2024; Principal Investigator/Mentor
  4. Elucidation of the miRNA-mediated Interferon modulations during early HSV-2 infection. ICMR-NARI: 2021-2024; Role: Principal Investigator
  5. Role of microRNAs in liver disease progression in HIV/HCV co-infected individuals. ICMR-NARI: 2020-2025; Role: Principal Investigator
  6. Elucidation of RNAi mediated interferon modulations during Human Papilloma Virus infection and study on the role of miRNAs in HPV-induced malignancies. ICMR-NARI: 2024-2026; Role: Principal Investigator
  7. National Program: Apex Laboratory for HIV-1 Viral Load testing and VLPT Program. NACO-MSACS: 2021-continuous; Role: In-Charge

Completed Projects :

  1. MicroRNAs and Exosomes: The Key Players in Rotavirus Infection. DST-SERB RAMANUJAN Fellowship Grant: 2016-2021; Role: Principal Investigator
  2. Study of regulation of RNA interference during rotavirus infection. DST-SERB: 2017-2020; Role: Co-Principal Investigator
Awards and Honours
  1. Travel Award – 13th International dsRNA Virus Symposium, Houffalize, Belgium, 2018
  2. DST-SERB RAMANUJAN Grant – SERB-DST, New Delhi, 2016
  3. ICMR-Research Associate – ICMR, New Delhi, 2016
  4. DST-SERB Young Scientist Award – SERB-DST, New Delhi, 2015
  5. UGC-DS Kothari Fellowship – UGC-DSKPDF Cell, Pune, 2015
  6. ICMR-PDF fellowship – ICMR, New Delhi, 2011
  7. Junior Scientist Travel Award – 14th ICID, Miami, USA, by DST, New Delhi, 2010
  8. Travel Award – 4th Euroepan Congress of Virology, Como, Italy, by ESCV, 2010
  9. ICMR-SRF fellowship – ICMR, New Delhi, 2009

Membership/Fellow of Professional Societies/Associations

  1. RAMANUJAN Fellow – Department of Science & Technology, Govt. of India
  2. Member of Project Selection Committee – ICMR, New Delhi
  3. Member of Technical Resource Group – Laboratory Services, NACO
  4. Member of Indian Science Congress Association
  5. Member of European Society for Clinical Virology
  6. Member of International Society for Infectious Diseases
  7. Editorial Board Member: MEEGID – Infection Genetics Evolution, Elsevier
  8. Associate Editor: Viruses (MDPI)
  9. Official Referee: 18 journals of Multidisciplinary Digital Publishing Institute (MDPI)
  10. Official Referee: 3 journals of Frontiers Media SA and Publishing Group (Frontiers)
  11. Official Referee: PLOS One (PLOS)
  12. Official Referee: Biological Research (BMC Springer Nature)
  13. Official Referee: Cancer Biomarkers (Hindawi)
  14. Official Referee: Virus Research (Elsevier)
  15. Official Referee: Archives of Medical Science (Termedia)
  16. Official Referee: Cancer Investigation (Taylor & Francis Group)
  17. Official Referee: Virus Research (Elsevier)
  18. Official Referee: Virulence (Taylor & Francis Group)
Work Experience
  1. Scientist E & Head, Division of Virology, ICMR-National AIDS Research Institute, Pune, India: 2023-Present
  2. Scientist D & Head, Division of Virology, ICMR-National AIDS Research Institute, Pune, India: 2021-2023
  3. Scientist D, Division of Virology, ICMR-National AIDS Research Institute, Pune, India: 2019-2021
  4. RAMANUJAN Scientist at ICMR-National Institute of Cholera & Enteric Diseases, Kolkata, India: 2016-2019
  5. DST Young Scientist at ICMR-National Institute of Cholera & Enteric Diseases, Kolkata, India: 2015-2016
  6. Research Scientist at ICMR-National Institute of Cholera & Enteric Diseases, Kolkata, India: 2015
  7. Postdoctoral Research Associate at Saint Louis University, Department of Pathology, Missouri, USA: 2013-2015
  8. Postdoctoral Research Fellow at ICMR-National Institute of Cholera & Enteric Diseases, Kolkata, India: 2011-2013
  9. Research Fellow at ICMR-National Institute of Cholera & Enteric Diseases, Kolkata, India: 2007-2011
List of Grant Recieved

Extramural (as PI): Ongoing - 4 & Completed - 4

Extramural (as Co-PI/Co-I): Ongoing - 5 & Completed - 2

Intramural (as PI): Ongoing – 3

Intramural (as Co-PI/Co-I): Ongoing - 1

  • Research Group:

     Research Fellows

  1. Dr. Pratiksha Jadaun, DHR Women Scientist
  2. Ms. Anwesha Banerjee, DHR Young Scientist
  3. Ms. Debashree Dass, CSIR-SRF
  4. Mr. Harshithkumar R UGC-SRF
  5. Mr. Anurag Singh DST-JRF

     Officers & Staff

  1. Ms. Madhuri Chandane-Tak, TO-B, ICMR-NARI
  2. Ms. Shraddha Y Gaikwad, TO-A, ICMR-NARI
  3. Ms. Ashwini More, Sr. Tech-2, ICMR-NARI
  4. Ms. Anuradha Vaidyanathan, Sr. Tech-1, ICMR-NARI
  5. Ms. Ishrat Khan, TO-NACO
  6. Ms. Aarti Randive, Lab Tech-NACO
  7. Ms. Vijaya Mane, DEO-YRG Care

     Alumni

  1. Dr. Sadhana Mutalik, Manipal College of Pharmaceutical Sciences, Manipal
  2. Mr. Kishore Dhotre, Doctoral Research Fellow, University of Erlangen-Nuremberg, Germany
Conference/Training/Workshop Attended
  1. Molecular Virology Meeting 2023, IISc. Bangalore, India: 2023
  2. ASM Microbe 2022 - online edition, Washington, D.C., USA: 2022
  3. 15th International Conference on MEEGID on Infectious Diseases - online edition, New Orleans, USA: 2021
  4. ESCV Virtual Meeting on Covid 19, Madrid, Spain: 2020
  5. 14th Vaccine Congress - online edition: Combatting the threat of COVID-19, Vaccine, Elsevier: 2020
  6. 22nd ESCV Annual Meeting, Copenhagen, Denmark: 2019
  7. Induction Program for ICMR Scientists at ICMR-NIRRH, Mumbai: 2019
  8. 6th Molecular Virology Meeting at IIT Kharagpur, India: 2019
  9. 13th International dsRNA Virus Symposium, Houffalize, Belgium: 2018
  10. Keystone Symposia: Cells vs. Pathogens: Intrinsic Defenses and Counter Defenses, California, USA: 2018
  11. 21st International Symposium on Hepatitis C Virus and Related Viruses, Banff, Canada: 2013
  12. 105th Annual Meeting of the American Association for Cancer Research (AACR), San Diego, California, USA: 2014
  13. 4th Euroepan Congress of Virology, Villa Erba Cernobbio, Como, Italy: 2010
  14. 14th International Congress on Infectious Diseases, Miami, USA: 2010
  15. 97th Indian Science Congress: Medical Sciences, ISRO, Thiruvanantapuram, India: 2010
  16. US - Japan CMSP: 13th International Conference on Emerging Infectious Diseases - Enteric Diseases: 2009
Number of Publications : 53
List of Publications

Patents & Publications: 53

List of Patents:

  1. Jadaun P, Harshithkumar R, Dass D, Banerjee A, Wakchaure P, Khan AA, Nema V, Mukherjee A#. A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HIV AND HSV INFECTION. Patent Application No. 202311055226, dt. Aug 17, 2023.

List of Publications:

  1. Mukherjee A# and Bagchi P. Editorial: Host Cell-Virus Interaction 2.0: Viral Stratagems of Immune Evasion, Host Cellular Responses and Antiviral Counterattacks. Viruses, 2023; Aug 4: Article In Press. [Impact factor – 5.818]
  2. Dhotre K, Dass D, Banerjee A, Nema V, Mukherjee A#. A computational approach for designing and validating small interfering RNA against SARS-CoV-2 variants. Curr Comput Aided Drug Des. 2023; July 22: Article In Press. [Impact factor – 1.7; Citation - 0]
  3. Jadaun P, Harshithkumar R, Gaikwad SY, Seniya C, Borse S, Gawai AA, Chavan-Gautam P, Tillu G, Mukherjee A#. Withania somnifera extracts induced attenuation of HIV-1: a mechanistic approach to restrict viral infection. Virol J. 2023; 20(1):173. [Impact factor – 4.8; Citation - 1]
  4. Shinde MD, Patil SA, Mukherjee A, Nema V. Revisiting the therapeutic potential of homeopathic medicine RhusTox for Herpes simplex virus and inflammatory conditions. J Ayurveda Integr Med. 2023; 14(4):100739. [Impact factor – 2.4; Citation - 0]
  5. Kamble S, Shidhaye P, Mukherjee A, Tak MC, Bembalkar S, Aggarwal S, Deb A, Kapoor N, Verma V, Das C, Kulkarni S, Ghate M, Godbole S. A protocol for feasibility of plasma based GeneXpert platform and Dried Blood Spot (DBS) based Abbott platform for HIV-1 Viral Load testing among the people living with HIV attending ART centers in India. PLoS ONE, 2023; 18(5):e0285942. [Impact factor – 3.752; Citation - 0]
  6. Gaikwad SY, Phatak P, Mukherjee A#. Cutting edge strategies for screening of novel anti-HIV drug candidates against HIV infection: A concise overview of cell based assays. Heliyon: Cell Press 2023; 9:e16027. [Impact factor – 4.0; Citation - 0]
  7. Khan I, Harshithkumar R, More A, Mukherjee A#. Human Papilloma Virus: An Unraveled Enigma of Universal Burden of Malignancies. Pathogens 2023;12(4):564. [Impact factor – 4.531; Citation - 2]
  8. Jadaun P, Shah P, Harshithkumar R, Said MS, Bhoite SP, Bokuri S, Ravindran S, Mishra N, Mukherjee A#. Antiviral and ROS scavenging potential of Carica papaya Linn and Psidium guajava leaves extract against HIV-1 infection. BMC Complement Med Ther. 2023;23(1):82. [Impact factor – 3.9; Citation - 2]
  9. Dass D, Dhotre K, Chakraborty M, Nath A, Banerjee A, Bagchi P, Mukherjee A#. miRNAs in Herpesvirus Infection: Powerful Regulators in Small Packages. Viruses. 2023;15(2):429. [Impact factor – 5.818; Citation - 2]
  10. Jadaun P, Seniya C, Pal SK, Kumar S, Kumar P, Nema V, Kulkarni SS, Mukherjee A#. Elucidation of Antiviral and Antioxidant Potential of C-Phycocyanin against HIV-1 Infection through In Silico and In Vitro Approaches. Antioxidants (Basel). 2022;11(10):1942. [Impact factor – 7.675; Citation - 3]
  11. Panda K and Mukherjee A#. Is monkeypox a threat to another pandemic? Front. Microbiol. 2022; 13:983076. [Impact factor – 6.064; Citation - 2]
  12. Joshi N, Chandane-Tak M and Mukherjee A#. The Involvement of microRNAs in HCV and HIV Infection. Ther Adv Vaccines Immunother. 2022; 10: 1–19. [Impact factor – 2.80; Citation - 5]
  13. Bhuinya A, Dass D, Banerjee A, Mukherjee A#. A tale of antiviral counterattacks in rotavirus infection. Microbiol Res. 2022; 260:127046. [Impact factor – 6.7; Citation - 5]
  14. Mukherjee A# and Bagchi P. Editorial: Host Cell-Virus Interaction. Viruses, 2022; 14(3):615. [Impact factor – 5.818]
  15. Banerjee A, Chawla-Sarkar M and Mukherjee A#. Rotavirus-Mediated Suppression of miRNA-192 Family and miRNA-181a Activates Wnt/β-Catenin Signaling Pathway: An In Vitro Study. Viruses, 2022; 14(3):558. [Impact factor – 5.818; Citation - 2]
  16. Banerjee A & Mukherjee A#. Herpesviridae and microRNAs. Intechopen.com. 2021; DOI: 10.5772/intechopen.100370. [Book Chapter; Downloads - 431]
  17. Nanaware N, Banerjee A, Mullick Bagchi S, Bagchi P, Mukherjee A#. Dengue Virus Infection: A Tale of Viral Exploitations and Host Responses. Viruses, 2021; 13(10):1967. [Impact factor – 5.818; Citation - 42]
  18. Mukhopadhyay U, Banerjee A, Chawla-Sarkar M and Mukherjee A#. Rotavirus Induces Epithelial–Mesenchymal Transition Markers by Transcriptional Suppression of miRNA-29b. Front Microbiol, 2021; 12:631183. [Impact factor – 6.064; Citation - 6]
  19. Klionsky DJ, et al. Among authors: Mukherjee A. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 2021; 1-382. doi: 10.1080/15548627.2020.1797280. [Impact factor – 16.016; Citation - 9890]
  20. Banerjee A, Kulkarni S, Mukherjee A#. Herpes Simplex Virus: The Hostile Guest That Takes Over Your Home. Front Microbiol, 2020; 11:733. [Impact factor – 6.064; Citation - 47]
  21. Saha P, Biswas M, Gupta R, Majumdar A, Mitra S, Banerjee A, Mukherjee A, Dutta S, Chawla-Sarkar M. Molecular characterization of Influenza A pandemic H1N1 viruses circulating in eastern India during 2017-19: Antigenic diversity in comparison to the vaccine strains. Infect Genet Evol, 2020; 81:104270. [Impact factor – 4.393; Citation - 4]
  22. Mukhopadhyay U, Chanda S, Patra U, Mukherjee A, Komoto S, Chawla-Sarkar M. Bi-phasic regulation of RNA interference during Rotavirus infection by modulation of Argonaute2. Cellular Microbiology, 2019; 21(12):e13101. [Impact factor – 4.288; Citation - 10]
  23. Mukhopadhyay U, Chanda S, Patra U, Mukherjee A, Rana S, Mukherjee A#, Chawla-Sarkar M. Synchronized Orchestration of miR-99b and let-7g Positively Regulates Rotavirus Infection by Modulating Autophagy. Scientific Reports, 2019; 9(1):1318. [Impact factor – 4.996; Citation - 21]
  24. Doan YH, Suzuki Y, Fujii Y, Haga K, Fujimoto A, Takai-Todaka R, Someya Y, Nayak MK, Mukherjee A, Imamura D, Shinoda S, Chawla-Sarkar M, Katayama K. Complex reassortment events of unusual G9P[4] rotavirus strains in India between 2011 and 2013. Infect Genet Evol, 2017; 54:417-428. [Impact factor – 4.393; Citation - 24]
  25. Mukherjee A, Nayak MK, Dutta S, Panda S, Satpati BR, Chawla-Sarkar M. Genetic Characterization of Circulating 2015 A(H1N1) pdm09 Influenza Viruses from Eastern India. PLoS ONE, 2016; 11(12):e0168464. [Impact factor – 3.752; Citation - 23]
  26. Mandal P, Mullick S, Nayak MK, Mukherjee A, Ganguly N, Niyogi P, Panda S, Chawla-Sarkar M. Complete genotyping of unusual species A rotavirus G12P[11] and G10P[14] isolates and evidence of frequent in vivo reassortment among the rotaviruses detected in children with diarrhea in Kolkata, India, during 2014. Arch Virol, 2016; 161(10):2773–2785. [Impact factor – 2.7; Citation - 16]
  27. Mukherjee A, Di Bisceglie AM, Ray RB. Hepatitis C Virus Mediated Enhancement of miR-373 Impairs JAK/STAT Signaling Pathway. J Virol, 2015; 89(6):3356-65. [Impact factor – 6.549; Citation - 80]
  28. Mullick S, Mukherjee A, Ghosh S, Pazhani GP, Sur D, Manna B, Nataro JP, Levine MM, Ramamurthy T, Chawla-Sarkar M. Community Based Case-Control Study of Rotavirus Gastroenteritis among Young Children during 2008-2010 Reveals Vast Genetic Diversity and Increased Prevalence of G9 Strains in Kolkata. PloS ONE, 2014; 9(11): e112970. [Impact factor – 3.752; Citation - 21]
  29. Ray RB, Mukherjee A, Shrivastava S, Ray R. Hepatitis C virus transcriptionally downregulates miR-181c for promotion of hepatocyte growth towards hepatocellular carcinoma. Cancer Research, 2014; 74(19): 3177-3177. [Impact factor – 13.312; Citation - 1]
  30. Mukherjee A, Shrivastava S, Chowdhury JB, Ray R, Ray RB. Transcriptional Suppression of miR-181c by Hepatitis C Virus Enhances Homeobox A1 Expression. J Virol, 2014; 88(14):7929-40. [Impact factor – 6.549; Citation - 65]
  31. Mukherjee A, Shrivastava S, Chowdhury JB, Ray R, Ray RB. Articles of Significant Interest Selected from This Issue by the Editors: Hepatitis C Virus-Mediated miR-181c Trans-Suppression Regulates Hepatocyte Growth. J Virol, 2014; 88(14):7691. DOI: 10.1128/JVI.01434-14. [Impact factor – 6.549]
  32. Shrivastava S*, Mukherjee A*, Ray RB. Hepatitis C virus infection, microRNA and liver disease progression. World J Hepatol, 2013; 5(9): 479-86. [Impact factor – 2.730; Citation - 85]
  33. Shrivastava S*, Mukherjee A*, Ray R, Ray RB. Hepatitis C Virus Induces IL-1β/IL-18 in Circulatory and Resident Liver Macrophages. J Virol, 2013; 87(22):12284-90. [Impact factor – 6.549; Citation - 142]
  34. Kang G, Desai R, Arora R, Chitamabar S, Naik TN, Krishnan T, Deshpande J, Gupte MD, S Venkatasubramaniam, Gentsch JR, Parashar UD, Mathew A, Anita S, Ramani S, Sowmynarayanan TV, Moses PD, Agarwal I, Simon A, Bose A, Arora R, Chhabra P, Fadnis P, Bhatt J, Shetty SJ, Saxena VK, Mathur M, Jadhav A, Roy S, Mukherjee A, Singh NB. Diversity of circulating rotavirus strains in children hospitalized with diarrhea in India, 2005-2009. Vaccine, 2013; 31(27):2879-2883. [Impact factor – 4.422; Citation - 105]
  35. Roy Mukherjee T, Mukherjee A, Chawla-Sarkar M. Full genomic analysis of human group C Influenza from eastern India. Infect Genet Evol, 2013; 16:419-25. [Impact factor – 4.393; Citation - 15]
  36. Chattopadhyay S, Basak T, Nayak MK, Bhardwaj G, Mukherjee A, Bhowmick R, Sengupta S, Chakrabarty O, Chatterjee NS, Chawla-Sarkar M. Identification of cellular calcium binding protein calmodulin as a regulator of rotavirus A infection during comparative proteomic study. PLoS ONE, 2013; 8(2): e56655. [Impact factor – 3.752; Citation - 37]
  37. Mullick S, Mukherjee A, Ghosh S, Pazhani GP, Sur D, Manna B, Nataro JP, Levine MM, Ramamurthy T, Chawla-Sarkar M. Genomic analysis of human rotavirus strains G6P[14] & G11P[25] isolated from Kolkata in 2009 reveals interspecies transmission and complex reassortment events. Infect Genet Evol, 2012; 14(1):15-21. [Impact factor – 4.393; Citation - 45]
  38. Mukherjee A, Mullick S, Deb AK, Panda S, Chawla-Sarkar M. First Report of Human Rotavirus G8P[4] Gastroenteritis in India: Evidence of Ruminants-to-Human Zoonotic Transmission. J Med Virol, 2012; 85:537–545. [Impact factor - 20.693; Citation - 40]
  39. Mukherjee A, Mullick S, Kobayashi N and Chawla-Sarkar M. The First Identification of Rare Human Group A Rotavirus Strain G3P[10] with Severe Infantile Diarrhea in Eastern India. Infect Genet Evol, 2012; 12(8):1933-7. [Impact factor – 4.393; Citation - 22]
  40. Mukherjee A, Chatopadhyay S and Chawla-Sarkar M. Rotavirus Infection in India: a major cause of childhood gastroenteritis. Proceedings of the National Academy of Science, India, 2012; 82(1):135–51. [Impact factor – 1.544; Citation - 1]
  41. Mukherjee A, Nayak MK, Roy T, Ghosh S, Naik TN, Kobayashi N, Chawla-Sarkar M. Detection of G10 Rotavirus Strains from Untypable Samples: Evidence for Interspecies Recombination in Human Group A Rotavirus Strains. Infect Genet Evol, 2012; 12(2):467-70. [Impact factor – 4.393; Citation - 33]
  42. Roy T, Agrawal AS, Mukherjee A, Mishra AC, Chadha MS, Kaur H, Chawla-Sarkar M. Surveillance and Molecular characterization of human influenza B viruses during 2006-2010 revealed co-circulation of Yamagata-like and Victoria-like strains in eastern India. Infect Genet Evol, 2011; 11(7):1595-601. [Impact factor – 4.393; Citation - 37]
  43. Mukherjee A, Ghosh S, Bagchi P, Dutta D, Chattopadhyay S, Kobayashi N, Chawla-Sarkar M. Full genomic analyses of human G4P[4], G4P[6], G9P[19] and G10P[6] strains from North-eastern India: Evidence for interspecies transmission and complex reassortment events. Clin Microbiol Infect, 2011; 17(9): 1343–6. [Impact factor – 14.2; Citation - 76]
  44. Dutta D, Chattopadhyay S, Bagchi P, Halder UC, Nandi S, Mukherjee A, Kobayashi N, Taniguchi K, Chawla-Sarkar M. Active participation of cellular chaperone Hsp90 in regulating the function of rotavirus nonstructural protein 3 (NSP3). J Biol Chem, 2011; 3; 286(22):20065-77. [Impact factor – 5.157; Citation - 39]
  45. Mukherjee A and Chawla-Sarkar M. Rotavirus Infection: A Perspective on Epidemiology, Genomic Diversity and Vaccine Strategies. Indian J Virol/VirusDiseases, 2011; 22(1):11–23. [Impact factor – 3.31; Citation - 25]
  46. Mukherjee A, Roy T, Agrawal AS, Sarkar M, Lal R, Chakrabarti S, Chawla-Sarkar M. Prevalence and epidemiology of pandemic H1N1 strains in hospitals of Eastern India. J Pub Health Epidemiol, 2010; 2(7): 171-4. [Citation - 50]
  47. Bagchi P, Dutta D, Chattopadhyay S, Mukherjee A, Halder UC, Sarkar S, Kobayashi N, Komoto S, Taniguchi K, Chawla-Sarkar M. Rotavirus Non-Structural Protein-1 suppresses virus induced cellular apoptosis to facilitate viral growth by activating the cell-survival pathways during early stages of infection. J Virol, 2010; 84(13):6834-45. [Impact factor – 6.549; Citation - 105]
  48. Mukherjee A, Chattopadhyay S, Bagchi P, Dutta D, Singh NB, Arora R, Parashar UD, Gentsch JR, Chawla-Sarkar M. Surveillance and molecular characterization of rotavirus strains circulating in Manipur, north-eastern India: Increasing prevalence of emerging G12 Strains. Infect Genet Evol, 2010; 10(2):311-20. [Impact factor – 4.393; Citation - 79]
  49. Chattopadhyay S, Bagchi P, Dutta D, Mukherjee A, Kobayashi N, Chawla-Sarkar M. Computational identification of the post-translational modification sites and the functional family prediction reveals possible moonlighting role of rotaviral proteins. Bioinformation, 2010; 4(10): 448-51. [Impact factor – 0.60; Citation - 20]
  50. Kang G, Arora R, Chitambar SD, Deshpande J, Gupte MD, Kulkarni M, Naik TN, Mukherji D, Venkatasubramaniam S, Gentsch JR, Glass RI, Parashar UD, Mathew A, Gonsalez A, Ramani S, Sowmynarayanan TV, Moses PD, Agarwal I, Simon A, Bose A, Arora R, Chhabra P, Fadnis P, Bhatt J, Shetty SJ, Saxena VK, Mathur M, Jadhav A, Roy S, Mukherjee A, Singh NB. Multicenter, hospital-based surveillance of rotavirus disease and strains among indian children aged <5 years. J Infect Dis. 2009; 200 Suppl 1:S147-53. [Impact factor – 7.759; Citation - 160]
  51. Dutta D, Bagchi P, Chatterjee A, Nayak M K, Mukherjee A, Chattopadhyay S, Nagashima S, Kobayashi N, Satoshi K, Taniguchi K, Chawla-Sarkar M. The Molecular Chaperone Heat Shock Protein-90 Positively Regulates Rotavirus Infection. Virology, 2009; 391(2):325-33. [Impact factor – 3.7; Citation - 62]
  52. Mukherjee A, Dutta D, Ghosh S, Bagchi P, Chattopadhyay S, Nagashima S, Kobayashi N, Dutta P, Krishnan T, Naik TN, Chawla-Sarkar M. Full genomic analysis of a human group A rotavirus G9P[6] strain from Eastern India provides evidence for porcine to human interspecies transmission. Arch Virol, 2009; 154(5):733-46. [Impact factor – 2.7; Citation - 68]

# Corresponding / Co-Corresponding Author; * Co-First Author

ORCID ID: orcid.org/0000-0002-0612-2258

Updated on September 2023 

Indian Council Of Medical Research
Ministry of Health & Family Welfare
Department of Health Research
Centralized Public grievance Redress and Monitoring System
PM India
The National Portal of India
National AIDS Control Organization
Indian Culture